文献速递产科母胎医学

胎儿异常的母体影响:一项基于人群的横断面研究

Maternal implications of fetal anomalies: a population-based cross-sectional study.
PubMed 文献 · Am J Obstet Gynecol MFM · 2024-07-31

该研究基于2011至2020年美国活产/婴儿死亡链接生命统计资料,纳入孕20周及以上的妊娠,按胎儿异常类型比较严重母体并发症(SMM)。结果显示,除腹裂和肢体异常外,各类胎儿异常均与SMM风险升高相关,且风险因异常类型而异。

要点

  • 研究纳入2011至2020年美国生命统计数据,孕20周及以上妊娠共35,760,626例。
  • 与无胎儿异常妊娠相比,无脑畸形、脐膨出、先天性心脏病等与SMM风险升高相关。
  • 腹裂和肢体异常与SMM风险升高无显著关联,其余异常类型的风险因类型而异。

核心结论

  • 胎儿异常与母体不良健康结局相关,严重母体并发症(SMM)风险因胎儿异常类型而异。
  • 作者认为,就胎儿异常对母体的影响向母亲提供咨询至关重要,有助于其对妊娠结局做出知情决策。

研究设计与样本

  • 研究为2011至2020年美国活产/婴儿死亡链接生命统计数据的重复横断面分析。
  • 纳入所有孕20周及以上的妊娠,共35,760,626例,其中无胎儿异常35,655,624例,孤立或多发胎儿异常105,002例。
  • 主要结局为严重母体并发症(SMM),定义为母体入住重症监护病房、输血、子宫破裂或子宫切除中的任一项。
  • 按胎儿异常类型与无任何胎儿异常妊娠比较,采用改良泊松回归计算调整相对危险度(aRR)及99%置信区间(99% CI),采用边际标准化预测边际法计算调整风险差(aRD)。

主要发现

  • 与无胎儿异常妊娠相比,除腹裂和肢体异常外,所有胎儿异常均与SMM风险升高相关,按aRR(99% CI)排序:唇裂和/或腭裂1.58(1.29-1.92);多发异常1.75(1.35-2.27);染色体病1.76(1.18-2.63);尿道下裂2.19(1.82-2.63);脊柱裂2.20(1.51-3.21);先天性膈疝2.39(1.62-3.53);先天性心脏病2.66(2.27-3.13);脐膨出3.15(2.08-4.76);无脑畸形3.27(2.22-4.80)。
  • 与无胎儿异常妊娠相比,除腹裂和肢体异常外,所有胎儿异常均与SMM绝对风险升高相关,按aRD(99% CI)排序:唇裂和/或腭裂0.26(0.12-0.40);多发异常0.34(0.13-0.55);染色体病0.34(0.02-0.66);尿道下裂0.54(0.36-0.72);脊柱裂0.54(0.17-0.92);先天性膈疝0.63(0.21-1.05);先天性心脏病0.75(0.56-0.95);脐膨出0.97(0.38-1.56);无脑畸形1.03(0.46-1.59)。

关键数值与推荐

  • SMM定义为母体入住重症监护病房、输血、子宫破裂或子宫切除中的任一项。
  • 数据集可提供的胎儿异常包括无脑畸形、脊髓脊膜膨出/脊柱裂、紫绀型先天性心脏病、先天性膈疝、脐膨出、腹裂、唇裂和/或腭裂、尿道下裂、肢体异常和染色体病;多于一种异常者归类为多发异常。

临床怎么用

  • 作者认为,就胎儿异常对母体的影响向母亲提供咨询至关重要,有助于其对妊娠结局做出知情决策。
  • 原文未据此给出其他临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although it is well-known that the presence of fetal anomalies is associated with maternal morbidity, granular information on these risks by type of anomaly is not available. OBJECTIVE: To examine adverse maternal outcomes according to the type of fetal anomaly. STUDY DESIGN: This was a repeated cross-sectional analysis of US vital statistics Live Birth/Infant Death linked data from 2011 to 2020. All pregnancies at 20 weeks or greater were included. Our primary outcome was severe maternal morbidity (SMM), defined as any maternal intensive care unit admission, transfusion, uterine rupture, or hysterectomy. Outcomes were compared between pregnancies with a specific type of fetal anomaly and pregnancies without any fetal anomaly. Fetal anomalies that were available in the dataset included anencephaly, meningomyelocele/spina bifida, cyanotic congenital heart disease, congenital diaphragmatic hernia, omphalocele, gastroschisis, cleft lip and/or palate, hypospadias, limb anomaly, and chromosomal disorders. If a fetus had more than one anomaly, it was classified as multiple anomalies. Adjusted relative risks (aRR) with 99% confidence intervals (99% CI) were calculated using modified Poisson regression. Adjusted risk differences (aRDs) were calculated using the marginal standardization form of predictive margins. RESULTS: Of 35,760,626 pregnancies included in the analysis, 35,655,624 pregnancies had no fetal anomaly and 105,002 had isolated or multiple fetal anomalies. Compared to pregnancies without fetal anomaly, all fetal anomalies were associated with an increased risk of SMM except for gastroschisis and limb anomaly in order of aRRs (99% CI): 1.58 (1.29-1.92) with cleft lip and/or palate; 1.75 (1.35-2.27) with multiple anomalies; 1.76 (1.18-2.63) with a chromosomal disorder; 2.19 (1.82-2.63) with hypospadias; 2.20 (1.51-3.21) with spina bifida; 2.39 (1.62-3.53) with congenital diaphragmatic hernia; 2.66 (2.27-3.13) with congenital heart disease; 3.15 (2.08-4.76) with omphalocele; and 3.27 (2.22-4.80) with anencephaly. Compared to pregnancies without fetal anomaly, all fetal anomalies were associated with an increased absolute risk of SMM except for gastroschisis and limb anomaly in order of aRDs (99% CI): 0.26 (0.12-0.40) with cleft lip and/or palate, 0.34 (0.13-0.55) with multiple anomalies, 0.34 (0.02-0.66) with a chromosomal disorder, 0.54 (0.36-0.72) with hypospadias, 0.54 (0.17-0.92) with spina bifida, 0.63 (0.21-1.05) with congenital diaphragmatic hernia, 0.75 (0.56-0.95) with congenital heart disease, 0.97 (0.38-1.56) with omphalocele, and 1.03 (0.46-1.59) with anencephaly. CONCLUSION: The presence of fetal anomalies is associated with adverse maternal health outcomes. The risk of SMM varies according to the type of fetal anomaly. Counseling mothers about the maternal implications of fetal anomalies is paramount to help them make informed decisions regarding their pregnancy outcome.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Atwani R, Aziz M, Saade G, et al. Maternal implications of fetal anomalies: a population-based cross-sectional study. Am J Obstet Gynecol MFM. 2024. PMID: 39089580. doi:10.1016/j.ajogmf.2024.101440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。